These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The prognostic value of immunologic markers in juvenile acute lymphatic leukemias and non-Hodgkin lymphomas]. Plüss HJ; Joller PW; Hitzig WH; Jakob M Schweiz Med Wochenschr; 1979 Sep; 109(37):1379-82. PubMed ID: 314664 [TBL] [Abstract][Full Text] [Related]
4. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Greaves MF; Janossy G; Peto J; Kay H Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165 [TBL] [Abstract][Full Text] [Related]
5. Lack of influence of T-cell marker and importance of mediastinal mass on the prognosis of acute lymphocytic leukemias of childhood. Hann HW; Lustbader ED; Evans AE; Toledano SR; Lillie PD; Jasko LB J Natl Cancer Inst; 1981 Feb; 66(2):285-90. PubMed ID: 6969813 [TBL] [Abstract][Full Text] [Related]
6. A clinical perspective on cell markers in acute lymphocytic leukemia. Bowman WP; Melvin SL; Aur RJ; Mauer AM Cancer Res; 1981 Nov; 41(11 Pt 2):4794-801. PubMed ID: 6975162 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF; Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166 [TBL] [Abstract][Full Text] [Related]
8. Peanut agglutinin, a marker for T-cell acute lymphoblastic leukemia with a good prognosis. Veerman AJ; Hogeman PH; Huismans DR; Van Zantwijk CH; Bezemer PD Cancer Res; 1985 Apr; 45(4):1890-3. PubMed ID: 3872169 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of early treatment response in children with acute myeloid leukemia]. Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861 [TBL] [Abstract][Full Text] [Related]
10. Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia. Dow LW; Borella L; Sen L; Aur RJ; George SL; Mauer AM; Simone JV Blood; 1977 Oct; 50(4):671-82. PubMed ID: 268981 [TBL] [Abstract][Full Text] [Related]
11. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission. Cáp J; Babusíková O; Kaiserová E; Jamárik M Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666 [TBL] [Abstract][Full Text] [Related]
12. Is T-cell acute lymphoblastic leukemia still a high risk leukemia in children? Cáp J; Foltinová A; Kaiserová E; Babusíková O; Jamárik M; Jasenková M Neoplasma; 1998; 45(3):135-9. PubMed ID: 9717524 [TBL] [Abstract][Full Text] [Related]
13. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected]. Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostik significance of cell membrane markers in childhood ALL (author's transl)]. Haas RJ; Netzel B; Janka GE; Rodt H; Thiel E; Thierfelder S Klin Padiatr; 1978 Sep; 190(5):446-52. PubMed ID: 309025 [TBL] [Abstract][Full Text] [Related]
15. The use of leukocyte acid phosphatase in the diagnosis of malignant disease. Case report and review of literature. Morse EE; Quinn J; Altman A; Talaizedeh M; Brassel J; Taubman S Ann Clin Lab Sci; 1980; 10(2):143-8. PubMed ID: 6966904 [TBL] [Abstract][Full Text] [Related]
16. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors. Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte markers in childhood ALL: the lack of correlation with prognosis. Cristo Morón E; Révész T; Schuler D Acta Paediatr Acad Sci Hung; 1982; 23(2):171-7. PubMed ID: 6982589 [TBL] [Abstract][Full Text] [Related]
18. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients. Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366 [TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP). Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914 [TBL] [Abstract][Full Text] [Related]
20. CALLA-negative, TdT- and CD7-positive acute lymphoblastic leukemia: a phenotype associated with poor prognosis. De Rossi G; Aloe Spiriti MA; Cafolla A; Gastaldi R; Lo Coco F; Lopez M; Luciani M; Pasqualetti D; Testi AM; Mandelli F Diagn Clin Immunol; 1987; 5(3):140-3. PubMed ID: 3319281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]